Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-07

Clinical Trial Update: IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study). [Phase 3]

View source ↗

Summary

Phase 3 trial BRAKE-AF evaluating ivabradine block of funny current for heart rate control in permanent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

Sponsor: Adolfo Fontenla | Conditions: Atrial Fibrillation, Heart Diseases | Phase 3 | Status: COMPLETED